The tissue grafts have the potential to help thousands of Americans on transplant waitlists—amid a shortage of donor livers.
Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a vascularized liver tissueoid-on-a-chip (LToC) platform that recapitulates key structural, functional, and immunological features of ...
More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD), characterized by a buildup of fat in the liver. This condition can lead ...
Two models more accurately replicate the physiology of the liver, offering a new way to test treatments for fat buildup. More than 100 million people in the United States suffer from metabolic ...
A liver tissueoid-on-a-chip with functional blood vessels, diverse liver cells, and immune activity replicates transplant ...
A diagnosis of serious liver disease can feel like a slow countdown. Scar tissue builds quietly, the liver stiffens, and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results